ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

462
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
15 Mar 2020 18:08

The Short Sell Ban Is Here

After tinkering with changes to the short sell rules, the Financial Services Commission (FSC) finally imposed a ban on short selling in the KOSPI,...

Logo
364 Views
Share
10 Mar 2020 18:04

FSC Tweaks Short Sell Rules; Shorts Jump on Samsung Electronics, KT&G, Hyundai Motors

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 6 March 2020.Current...

Logo
332 Views
Share
09 Mar 2020 10:30

Korea's Low Dividend Stocks Facing Pressure From Institutional Investors

Korean companies have historically carried fairly low dividend yields, which is one of the key factors driving the so-called "Korea Discount". As...

Logo
359 Views
Share
04 Mar 2020 13:47

Korea - Potential Short Sell Ban

With Indonesia's ban on short selling that started on Monday, there is chatter in Korea about a temporary ban on short selling and following the...

Logo
433 Views
Share
04 Mar 2020 06:59

Korea - Technology Covering Offsets Shorts in Other Sectors

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 28 February...

Logo
349 Views
Share
x